Molecular basis of hyperparathyroidism and potential targets for drug development.

Current drug targets. Immune, endocrine and metabolic disorders

Volumn 2, Issue 2, 2002, Pages 167-179

  Krebs, L J ^a   Arnold, A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL RECEPTOR; CALCIUM; CALCIUM SENSING RECEPTOR; CELL SURFACE RECEPTOR; CYCLIN D1; PARATHYROID HORMONE; PHOSPHATE;

ANIMAL; GENETICS; HUMAN; HYPERPARATHYROIDISM; METABOLISM; MULTIPLE ENDOCRINE NEOPLASIA; PHYSIOLOGY; PROTO ONCOGENE; REVIEW; SECRETION; TUMOR SUPPRESSOR GENE;

ANIMALS; CALCIUM; CYCLIN D1; GENES, BCL-1; GENES, TUMOR SUPPRESSOR; HUMANS; HYPERPARATHYROIDISM; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PARATHYROID HORMONE; PHOSPHATES; RECEPTORS, CALCITRIOL; RECEPTORS, CALCIUM-SENSING; RECEPTORS, CELL SURFACE;

EID: 0036635771     PISSN: 15680088     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568005310202020167     Document Type: Review

References (111)